{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Palisade Bio, Inc."},"Symbol":{"label":"Symbol","value":"PALI"},"Address":{"label":"Address","value":"5800 ARMADA DRIVE,SUITE 210 SUITE 2A, CARLSBAD, California, 92008, United States"},"Phone":{"label":"Phone","value":"+1 858 704-4900"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery."},"CompanyUrl":{"label":"Company Url","value":"https://www.palisadebio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"J. D. Finley","title":"Chief Executive & Financial Officer, Director"},{"name":"Joie Bernard","title":"Senior Director-Clinical & Translational Research"},{"name":"Mitchell Lawrence Jones","title":"Chief Medical Officer"},{"name":"Nicholas McCoy","title":"VP-Clinical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}